Analyst Upgrades: TransEnterix, Inc., Ollie's Bargain Outlet Holdings Inc, and Bed Bath & Beyond Inc.

Analysts upwardly revised their ratings and price targets on TransEnterix, Inc. (NYSEMKT:TRXC), Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI), and Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Josh Selway

Apr 7, 2016 at 9:18 AM

Analysts are weighing in on medical device stock TransEnterix, Inc. (NYSEMKT:TRXC), as well as retailers Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI) and Bed Bath & Beyond Inc. (NASDAQ:BBBY). Here's a quick roundup of today's bullish brokerage notes on TRXC, OLLI, and BBBY.

TRXC is set to add another 3.4% this morning, as excitement builds ahead of a key Food and Drug Administration (FDA) decision. The stock has added over 30% this week, closing Wednesday at $5.69 after tapping an annual high of $6.10. With bulls rushing into TransEnterix, Inc.'s options pits, analysts are also getting in on the action. Lake Street this morning reiterated its "buy" opinion on the shares, along with a $7 price target. However, this is just more of the same from Wall Street, where every single brokerage tracking TRXC recommends buying it.

OLLI is pointed almost 10% higher in electronic trading, thanks to better-than-expected fiscal fourth-quarter earnings. The stock has already outpaced the S&P 500 Index (SPX) by nearly 16 percentage points in the past three months to trade at $22.70, but analysts are still expecting more. Just this morning, Piper Jaffray upped its rating on Ollie's Bargain Outlet Holdings Inc to "overweight," with a price-target hike to $28. No fewer than three other analysts also raised their price targets, which may have short sellers scared. More than one-fourth of OLLI's float is sold short, accounting for 12 sessions' worth of trading, at the stock's typical daily volume.

BBBY is eyeing a 2.6% pop when the market opens, after the company beat the Street's expectations in the earnings confessional and announced a new quarterly dividend. Goldman Sachs and Baird raised their respective price targets on Bed Bath & Beyond Inc. to $52 and $51, and there's a good chance the stock could receive more bullish attention in the near term. Specifically, just one of the 17 brokerages tracking BBBY recommends buying it. And at their Wednesday close of $48.81, the shares are up more than 18% since hitting a five-year low of $41.26 in early February.

Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.